Bioventus (BVS) Depreciation & Amortization (CF) (2020 - 2026)

Bioventus' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 5.56% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (down 6.62% YoY) and the FY2025 annual result came in at $47.0 million, down 5.13% from the prior year.
• Depreciation & Amortization (CF) was $11.2 million for Q1 2026 at Bioventus, down from $11.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $16.9 million in Q4 2022 and bottomed at $11.2 million in Q1 2026.
• A 5-year average of $13.0 million and a median of $12.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 73.71% — and 2024, when it dropped 28.46%.
• Bioventus' Depreciation & Amortization (CF) stood at $16.9 million in 2022, then fell by 26.43% to $12.5 million in 2023, then dropped by 0.48% to $12.4 million in 2024, then dropped by 5.73% to $11.7 million in 2025, then dropped by 4.18% to $11.2 million in 2026.
• Business Quant data shows BVS's Depreciation & Amortization (CF) at $11.2 million in Q1 2026, $11.7 million in Q4 2025, and $11.4 million in Q3 2025.